U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• Box Office: ‘How to Train Your Dragon’ to Fly to $75 Million in Opening Weekend - Variety
• Ryu Ga Gotoku Studio's Project Century Gets A Strange New Title - GameSpot
• How exactly do things get smuggled into prison? Does the sender hide it inside something else very well? Does someone put it in their butt? Do the prisoners make deals with the officers?
• Why doesn't speeding significantly decrease one’s commute time? I've done a lot of road trips and driving and have experimented by increasing speed by 10–20%, but somehow this never equates to arriving 20% sooner, even on clear roads.
• James Webb Space Telescope Has Spotted Something “Abnormal, Chaotic, and Strange” 60 Light-Years from Earth - The Debrief
• James Webb Space Telescope sees 1st exoplanet raining sand alongside 'sandcastle' partner world - Space
• No One in the Movies Stays Dead Anymore - Yahoo
• Fans Swoon Over ‘Still Smokin Hot' ’80s Singer, 64, As Band Reunites for the First Time in 40 Years - Yahoo
• Renck: If J.K. Dobbins stays healthy, he’ll be reason Broncos win AFC West - The Denver Post
• Can a barracuda kill a human?